Florian Strassheimer

Dr. Senckenberg Institute Of Neurooncology
Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.

Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.

Journal: Molecular therapy. Oncology

Published: March 02, 2026

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

Journal: British journal of cancer

Published: June 05, 2024

Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1.

Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1.

Journal: Cell death discovery

Published: March 28, 2024

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.

Journal: Neuro-oncology

Published: May 06, 2023

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.

Journal: Oncoimmunology

Published: October 17, 2022

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.

Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.

Journal: Molecular cancer

Published: March 29, 2022

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.

Journal: Cancers

Published: July 10, 2020

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.

Journal: Frontiers in immunology

Published: August 30, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026